Banner Text

Banner Slogan
Member Login
User Name:
Password:
Register
Street Address
Suburb Postcode
STATE  Australia
Tel Phone
Fax Fax
Email Us

Business Development

Intellectual Property

HealthLinx’s IP Portfolio includes

 

  • PCT patent for OvPlex™, ovarian cancer diagnostic
  • Patents progressing to national phase for Mab’s used in the OvPlex™ panel and future pipeline targets
  • Patents granted for Vascular Permeability covering compound and target
  • 3 additional patents in the area of Vascular Permeability entering national phase
  • Granted patent covering Protein/immuno depletion technology (ClearIT™) in Europe (in examination in other jurisdictions including the US and Asia)